South Wales, April 10 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "FOCALIS BIO" on March 26. The details about the trademark application no. UK00004362235 published in the journal no. 2026/015 (April 10).
With Stratagem Intellectual Property Management Limited as representative, EPILEPSYGTX LIMITED filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical and medical preparations for therapeutic purposes; biological preparations for medical use in cell and gene therapies; pharmaceutical and medical preparations and substances for the prevention, diagnosis and treatment of epilepsy and other disorders of neuronal hyperexcitability, including Parkinson's disease, schizophrenia, migraine and cluster headache and OCD; reagents for use in medical genetic testing; pharmaceutical and biopharmaceutical preparations for cell and gene therapies; gene therapy products for medical use; medical preparations containing therapeutic DNA and RNA; preparations for genetically modifying human or animal cells for medical purposes; biological, chemical and biochemical reagents for medical use; cells for medical or clinical use; drug delivery agents consisting of capsids that facilitate delivery of pharmaceuticals and biopharmaceuticals for medical use; vaccines.
Class 42 : Scientific and industrial research and analysis in the field of life sciences; pharmaceutical and biopharmaceutical drug development services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development to develop novel capsids for genetic delivery of gene therapies and pharmaceuticals; research and development of pharmaceutical preparations for gene and cell therapies; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery; medical research laboratory services; providing scientific research information on the prevention, diagnosis, and treatment of epilepsy and other disorders of neuronal hyperexcitability, including Parkinson's disease, schizophrenia, migraine and cluster headache and OCD; providing a website featuring medical information and medical research; clinical trials; scientific and medical research and development in the field of gene therapy; providing a website featuring information in the field of gene therapy research; consultancy and advisory services related to research and development in the fields of medicine, vaccines and gene therapy.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004362235
Disclaimer: Curated by HT Syndication.
